Merck Cited For Violations At Vaccines Plant; FDA Seeks A Meeting With CEO
Executive Summary
FDA is seeking a meeting with Merck CEO Richard Clark to address current good manufacturing practice violations at the firm's West Point, Pa., vaccines plant - an unusual request reflecting the significance not just of the deficiencies but of the products manufactured at the facility, which include Merck's top-selling cervical cancer vaccine Gardasil.